{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:46:03Z","timestamp":1762332363877,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ejpb.2025.114690","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:18:50Z","timestamp":1741202330000},"page":"114690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel long-acting phospholipid phase transition gel with progesterone effectively promoted uterine development"],"prefix":"10.1016","volume":"210","author":[{"given":"Bing","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengling","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianwen","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114690_b0005","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.molmed.2023.05.009","article-title":"Immunobiology of pregnancy: from basic science to translational medicine","volume":"29","author":"Colamatteo","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejpb.2025.114690_b0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and Management of Infertility A Review","volume":"326","author":"Carson","year":"2021","journal-title":"Jama-J Am Med Assoc"},{"key":"10.1016\/j.ejpb.2025.114690_b0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-077111","article-title":"Achieving more equitable access to assisted reproduction","volume":"385","author":"Dyer","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.ejpb.2025.114690_b0020","first-page":"156","article-title":"A History of Developments to Improve in vitro Fertilization","volume":"114","author":"Eskew","year":"2017","journal-title":"Mo Med"},{"key":"10.1016\/j.ejpb.2025.114690_b0025","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41574-023-00921-5","article-title":"Luteal phase support in assisted reproductive technology","volume":"20","author":"Garg","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ejpb.2025.114690_b0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214138","article-title":"Progesterone: The Key Factor of the Beginning of Life","volume":"23","author":"Bulletti","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejpb.2025.114690_b0035","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.rbmo.2018.02.001","article-title":"Systematic review of the clinical efficacy of vaginal progesterone for luteal phase support in assisted reproductive technology cycles","volume":"36","author":"Child","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejpb.2025.114690_b0040","first-page":"296","article-title":"Progesterone and Early Pregnancy Bleeding","volume":"322","author":"Slomski","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.ejpb.2025.114690_b0045","article-title":"NICE recommends progesterone to prevent early miscarriage","volume":"375","author":"Wise","year":"2021","journal-title":"Bmj-Brit Med J"},{"key":"10.1016\/j.ejpb.2025.114690_b0050","article-title":"Preparation and pharmacokinetics study of albumin-coated crystalline progesterone long-acting microcapsules for injection","volume":"88","author":"Sun","year":"2023","journal-title":"J Drug Deliv Sci Tec"},{"key":"10.1016\/j.ejpb.2025.114690_b0055","article-title":"Diagnostic and therapeutic use of oral micronized progesterone in endocrinology","author":"Memi","year":"2024","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.ejpb.2025.114690_b0060","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1208\/s12249-024-02747-4","article-title":"Enhanced Oral Bioavailability of Progesterone in Bilosome Formulation: Fabrication","volume":"25","author":"Maheshwari","year":"2024","journal-title":"Statistical Optimization, and Pharmacokinetic Study, AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2025.114690_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bcpt.13802","article-title":"Mechanism insight into the in situ reactions of repeated intramuscular progesterone injections","volume":"132","author":"Zhang","year":"2023","journal-title":"Basic Clin Pharmacol"},{"key":"10.1016\/j.ejpb.2025.114690_b0070","doi-asserted-by":"crossref","DOI":"10.1378\/chest.1119599","article-title":"Acute Eosinophilic Pneumonia Caused by Intramuscular Injections of Progesterone","volume":"140","author":"Shariat","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.ejpb.2025.114690_b0075","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jsps.2019.09.006","article-title":"Progesterone loaded thermosensitive hydrogel for vaginal application: Formulation and comparison with commercial product","volume":"27","author":"Vel\u00e1zquez","year":"2019","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.ejpb.2025.114690_b0080","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jconrel.2018.12.046","article-title":"Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth","volume":"295","author":"Hoang","year":"2019","journal-title":"J Control Release"},{"key":"10.1016\/j.ejpb.2025.114690_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123250","article-title":"Advances in progesterone delivery systems: Still work in progress?","volume":"643","author":"Patil","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2025.114690_b0090","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejpb.2025.114690_b0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2147\/IJN.S12947","article-title":"Sustained-release progesterone nanosuspension following intramuscular injection in ovariectomized rats","volume":"5","author":"Salem","year":"2010","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.ejpb.2025.114690_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115003","article-title":"Polymeric in situ forming depots for long-acting drug delivery systems","volume":"200","author":"Pandya","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2025.114690_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113957","article-title":"Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants","volume":"177","author":"Abdelkader","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2025.114690_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: From 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ejpb.2025.114690_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114901","article-title":"Recent advances in lipid-based long-acting injectable depot formulations","volume":"199","author":"Sharma","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2025.114690_b0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.actbio.2017.11.057","article-title":"Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia","volume":"67","author":"Mei","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.ejpb.2025.114690_b0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jconrel.2022.06.062","article-title":"Lyotropic liquid crystals for parenteral drug delivery","volume":"349","author":"Chavda","year":"2022","journal-title":"J Control Release"},{"key":"10.1016\/j.ejpb.2025.114690_b0130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jconrel.2017.02.022","article-title":"Solvent removal precipitation based in situ forming implant for controlled drug delivery in periodontitis","volume":"251","author":"Juvekar","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.ejpb.2025.114690_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: A smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.ejpb.2025.114690_b0140","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1021\/jacs.9b11057","article-title":"Phase Separation in Atomistic Simulations of Model Membranes","volume":"142","author":"Gu","year":"2020","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.ejpb.2025.114690_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122887","article-title":"Assessment of glyceride-structured oleogels as an injectable extended-release delivery system of bupivacaine","volume":"637","author":"Wojtalewicz","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2025.114690_b0150","doi-asserted-by":"crossref","unstructured":"N. Patil, R. Maheshwari, S.J.I.J.o.P. Wairkar, Advances in progesterone delivery systems: Still work in progress?, 643 (2023).","DOI":"10.1016\/j.ijpharm.2023.123250"},{"key":"10.1016\/j.ejpb.2025.114690_b0155","volume":"15","author":"Wang","year":"2024","journal-title":"Cholesterol-Modified Sphingomyelin Chimeric Lipid Bilayer for Improved Therapeutic Delivery"},{"key":"10.1016\/j.ejpb.2025.114690_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2014.12.042","article-title":"A high-efficiency, low-toxicity, phospholipids-based phase separation gel for long-term delivery of peptides","volume":"45","author":"Zhang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2025.114690_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114862","article-title":"Long-acting parenteral drug delivery systems for the treatment of chronic diseases","volume":"198","author":"Jindal","year":"2023","journal-title":"Adv Drug Deliver Rev"},{"key":"10.1016\/j.ejpb.2025.114690_b0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ijpharm.2010.05.042","article-title":"Rheological characterization and in vivo evaluation of thermosensitive poloxamer-based hydrogel for intramuscular injection of piroxicam","volume":"395","author":"Xuan","year":"2010","journal-title":"Int J Pharmaceut"},{"key":"10.1016\/j.ejpb.2025.114690_b0175","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/humupd\/dmm023","article-title":"Progesterone receptor modulators and the endometrium: changes and consequences","volume":"13","author":"Horne","year":"2007","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.ejpb.2025.114690_b0180","first-page":"1443","article-title":"Infertility Affects 1 in 6 People Globally","volume":"329","author":"Harris","year":"2023","journal-title":"Jama-J Am Med Assoc"},{"key":"10.1016\/j.ejpb.2025.114690_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121021","article-title":"Novel injectable progesterone-loaded nanoparticles embedded in SAIB-PLGA in situ depot system for sustained drug release","volume":"607","author":"Cao","year":"2021","journal-title":"Int J Pharm"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:40:11Z","timestamp":1762332011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125000669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":37,"alternative-id":["S0939641125000669"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114690","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel long-acting phospholipid phase transition gel with progesterone effectively promoted uterine development","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114690"}}